SE0104251D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0104251D0 SE0104251D0 SE0104251A SE0104251A SE0104251D0 SE 0104251 D0 SE0104251 D0 SE 0104251D0 SE 0104251 A SE0104251 A SE 0104251A SE 0104251 A SE0104251 A SE 0104251A SE 0104251 D0 SE0104251 D0 SE 0104251D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- formula
- therapy
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0104251A SE0104251D0 (sv) | 2001-12-14 | 2001-12-14 | Novel compounds |
DK02793633T DK1499590T3 (da) | 2001-12-14 | 2002-12-11 | Piperidinderivater som kaliumkanalblokkere |
PT02793633T PT1499590E (pt) | 2001-12-14 | 2002-12-11 | Derivados de piperdina como bloqueadores do canal de potassio |
PCT/SE2002/002304 WO2003051839A1 (fr) | 2001-12-14 | 2002-12-11 | Nouveaux composes |
AU2002359122A AU2002359122A1 (en) | 2001-12-14 | 2002-12-11 | Novel compounds |
SI200230342T SI1499590T1 (sl) | 2001-12-14 | 2002-12-11 | Piperidinski derivati kot blokatorji kalijevih kanalov |
EP02793633A EP1499590B8 (fr) | 2001-12-14 | 2002-12-11 | Dérivés de pipéridine comme agents bloquants du canal potassium |
AT02793633T ATE325095T1 (de) | 2001-12-14 | 2002-12-11 | Piperidinderivate als kalium-kanal blockers |
CA002487365A CA2487365C (fr) | 2001-12-14 | 2002-12-11 | Derives de piperidine utilises comme bloqueurs des canaux potassiques |
ES02793633T ES2261773T3 (es) | 2001-12-14 | 2002-12-11 | Derivados de piperidina como bloqueantes del canal de potasio. |
DE60211223T DE60211223T2 (de) | 2001-12-14 | 2002-12-11 | Piperidinderivate als Kalium-Kanal Blockers |
MYPI20024681A MY128924A (en) | 2001-12-14 | 2002-12-13 | Novel compounds |
TW091136138A TWI255185B (en) | 2001-12-14 | 2002-12-13 | Novel compounds |
HK05103887A HK1071134A1 (en) | 2001-12-14 | 2005-05-09 | Piperidine derivatives as potassium channel blockers |
CY20061101043T CY1106132T1 (el) | 2001-12-14 | 2006-07-27 | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0104251A SE0104251D0 (sv) | 2001-12-14 | 2001-12-14 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0104251D0 true SE0104251D0 (sv) | 2001-12-14 |
Family
ID=20286353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0104251A SE0104251D0 (sv) | 2001-12-14 | 2001-12-14 | Novel compounds |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1499590B8 (fr) |
AT (1) | ATE325095T1 (fr) |
AU (1) | AU2002359122A1 (fr) |
CA (1) | CA2487365C (fr) |
CY (1) | CY1106132T1 (fr) |
DE (1) | DE60211223T2 (fr) |
DK (1) | DK1499590T3 (fr) |
ES (1) | ES2261773T3 (fr) |
HK (1) | HK1071134A1 (fr) |
MY (1) | MY128924A (fr) |
PT (1) | PT1499590E (fr) |
SE (1) | SE0104251D0 (fr) |
TW (1) | TWI255185B (fr) |
WO (1) | WO2003051839A1 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
US8017762B2 (en) | 2003-04-17 | 2011-09-13 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
US7851615B2 (en) | 2003-04-17 | 2010-12-14 | Alnylam Pharmaceuticals, Inc. | Lipophilic conjugated iRNA agents |
US7723509B2 (en) | 2003-04-17 | 2010-05-25 | Alnylam Pharmaceuticals | IRNA agents with biocleavable tethers |
US8796436B2 (en) | 2003-04-17 | 2014-08-05 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
EP2669377A3 (fr) | 2003-04-17 | 2015-10-14 | Alnylam Pharmaceuticals Inc. | Agents iARN modifiés |
EP1912942A1 (fr) * | 2005-08-01 | 2008-04-23 | AstraZeneca AB | Nouveaux dérivés de pipéridine en tant que modulateurs de récepteur de chimiokine utiles pour le traitement des affections respiratoires |
TW200734305A (en) * | 2005-08-02 | 2007-09-16 | Astrazeneca Ab | New salt III |
TW200738635A (en) * | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
TW200738634A (en) * | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
BRPI0615064A2 (pt) * | 2005-08-26 | 2011-05-03 | Astrazeneca Ab | combinação de compostos que pode ser usada no tratamento de doenças respiratórias, especialmente, doença pulmonar obstrutiva crÈnica (dpoc) e asma |
TW200744612A (en) * | 2005-08-26 | 2007-12-16 | Astrazeneca Ab | New combination |
ES2340604T3 (es) | 2005-12-21 | 2010-06-07 | F. Hoffmann-La Roche Ag | Lineas celulares estables que expresan herg. |
US20080064884A1 (en) * | 2006-05-10 | 2008-03-13 | Astrazeneca Ab | Novel Process 1 |
GB0702456D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
US20110136843A1 (en) * | 2007-02-23 | 2011-06-09 | Tomas Eriksson | Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma |
WO2008121065A1 (fr) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | Nouveaux dérivés de pyrrolidine utilisés comme antagonistes du récepteur de chimiokines |
JP2011507593A (ja) | 2007-12-20 | 2011-03-10 | アストラゼネカ・アクチエボラーグ | 粉末854を脱凝集解体する装置ならびに方法 |
US9289565B2 (en) | 2008-10-08 | 2016-03-22 | Astrazeneca Ab | Inhaler with indexing linked to movement of cover |
TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
NZ597009A (en) | 2009-07-01 | 2014-05-30 | Astrazeneca Ab | Dispenser and method for entraining powder in an airflow |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011061527A1 (fr) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinaisons qui comprennent un modulateur du récepteur glucocorticoïde, destinées au traitement de maladies respiratoires |
WO2011073662A1 (fr) | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Association d'une benzoxazinone et d'un autre agent pour le traitement de maladies respiratoires |
CA2788015A1 (fr) | 2010-02-10 | 2011-08-18 | Astrazeneca Uk Limited | Procede pour fournir une cartouche remplie pour un inhalateur |
US20140000601A1 (en) | 2010-07-21 | 2014-01-02 | Astrazeneca Ab | Inhaler |
CN103118726B (zh) | 2010-07-21 | 2015-07-22 | 阿斯利康(瑞典)有限公司 | 吸入器 |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
WO2012163848A1 (fr) | 2011-05-27 | 2012-12-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés et compositions pharmaceutiques destinés au traitement de la maladie de crohn |
GB201115874D0 (en) | 2011-09-14 | 2011-10-26 | Astrazeneca Ab | Inhaler |
GB201115870D0 (en) | 2011-09-14 | 2011-10-26 | Astrazeneca Ab | Inhaler |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5300399A1 (es) * | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen |
-
2001
- 2001-12-14 SE SE0104251A patent/SE0104251D0/xx unknown
-
2002
- 2002-12-11 WO PCT/SE2002/002304 patent/WO2003051839A1/fr not_active Application Discontinuation
- 2002-12-11 DE DE60211223T patent/DE60211223T2/de not_active Expired - Lifetime
- 2002-12-11 AT AT02793633T patent/ATE325095T1/de not_active IP Right Cessation
- 2002-12-11 AU AU2002359122A patent/AU2002359122A1/en not_active Abandoned
- 2002-12-11 PT PT02793633T patent/PT1499590E/pt unknown
- 2002-12-11 EP EP02793633A patent/EP1499590B8/fr not_active Expired - Lifetime
- 2002-12-11 DK DK02793633T patent/DK1499590T3/da active
- 2002-12-11 ES ES02793633T patent/ES2261773T3/es not_active Expired - Lifetime
- 2002-12-11 CA CA002487365A patent/CA2487365C/fr not_active Expired - Fee Related
- 2002-12-13 TW TW091136138A patent/TWI255185B/zh not_active IP Right Cessation
- 2002-12-13 MY MYPI20024681A patent/MY128924A/en unknown
-
2005
- 2005-05-09 HK HK05103887A patent/HK1071134A1/xx not_active IP Right Cessation
-
2006
- 2006-07-27 CY CY20061101043T patent/CY1106132T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2261773T3 (es) | 2006-11-16 |
PT1499590E (pt) | 2006-08-31 |
DK1499590T3 (da) | 2006-07-31 |
CA2487365A1 (fr) | 2003-06-26 |
WO2003051839A1 (fr) | 2003-06-26 |
MY128924A (en) | 2007-02-28 |
EP1499590A1 (fr) | 2005-01-26 |
DE60211223T2 (de) | 2007-04-19 |
ATE325095T1 (de) | 2006-06-15 |
DE60211223D1 (de) | 2006-06-08 |
CA2487365C (fr) | 2009-06-16 |
CY1106132T1 (el) | 2011-06-08 |
TWI255185B (en) | 2006-05-21 |
EP1499590B1 (fr) | 2006-05-03 |
TW200409631A (en) | 2004-06-16 |
HK1071134A1 (en) | 2005-07-08 |
EP1499590B8 (fr) | 2006-08-02 |
AU2002359122A1 (en) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0104251D0 (sv) | Novel compounds | |
IS6658A (is) | Ný efnasambönd | |
PT1263724E (pt) | Novos compostos | |
SE0104140D0 (sv) | Novel Compounds | |
SE0301700D0 (sv) | Novel compounds | |
ATE316083T1 (de) | Adamantanderivate | |
SE0300480D0 (sv) | Novel compounds | |
SE0202539D0 (sv) | Compounds | |
SE0103836D0 (sv) | Novel compounds | |
SE0302139D0 (sv) | Novel compounds | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
TW200604197A (en) | New compounds | |
MY133969A (en) | Indoloquinazolinones | |
DE60301339D1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
SE0101038D0 (sv) | Novel compounds | |
SE0102716D0 (sv) | Novel compounds | |
GB0120461D0 (en) | Novel compounds | |
SE0003476D0 (sv) | Compounds | |
SE0303280D0 (sv) | Novel compounds | |
SE0401763D0 (sv) | Compounds | |
TR200401052T4 (tr) | Yeni bileşikler | |
SE0202693D0 (sv) | Compounds | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
SE0302755D0 (sv) | Novel compounds | |
SE0202692D0 (sv) | Compounds |